Manganese deficiency

Also known as: Manganese deficiency (disorder)

Drug	Drug Name	Drug Description
DB06757	Manganese cation	A transition metal used for supplementation of manganese during Total Parenteral Nutrition (TPN).

Drug	Drug Name	Target	Type
DB06757	Manganese cation	Cytoplasmic aconitate hydratase	enzyme
DB06757	Manganese cation	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	target
DB06757	Manganese cation	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	target
DB06757	Manganese cation	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	target
DB06757	Manganese cation	Arginase-1	target
DB06757	Manganese cation	Serotransferrin	carrier
DB06757	Manganese cation	Serum albumin	carrier
DB06757	Manganese cation	Zinc transporter ZIP14	transporter
DB06757	Manganese cation	Superoxide dismutase [Mn], mitochondrial	target
DB06757	Manganese cation	Glutamine synthetase	target
DB06757	Manganese cation	Phosphoenolpyruvate Carboxykinases	target
DB06757	Manganese cation	Natural resistance-associated macrophage protein 2	transporter
DB06757	Manganese cation	Zinc transporter 10	transporter
DB06757	Manganese cation	Ceruloplasmin	carrier
DB06757	Manganese cation	Transient receptor potential cation channel subfamily M member 7	transporter
DB06757	Manganese cation	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	target

Drug	Drug Name	Phase	Status	Count